| Bioactivity | Pelcitoclax (APG-1252) is a potent Bcl-2/Bcl-xl inhibitor with antineoplastic and pro-apoptotic effects[1]. | ||||||||||||
| Invitro | APG-1252 changes to the reactive metabolite named APG-1252-M1, which has remarkable antitumor effects in acute myeloid leukemia[1]. | ||||||||||||
| Name | Pelcitoclax | ||||||||||||
| CAS | 1619923-36-2 | ||||||||||||
| Formula | C57H66ClF4N6O11PS4 | ||||||||||||
| Molar Mass | 1281.85 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Pelcitoclax
CAS: 1619923-36-2 F: C57H66ClF4N6O11PS4 W: 1281.85
Pelcitoclax (APG-1252) is a potent Bcl-2/Bcl-xl inhibitor with antineoplastic and pro-apoptotic effects.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.